tetrakis(2-[4-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexyl]propan-2-ol);2-[(1R,3R)-3-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclopentyl]propan-2-ol;2-[4-[[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]methyl]cyclohexyl]propan-2-ol;2-[4-[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]oxycyclohexyl]propan-2-ol

C154H195N27O8 — CID 157477956

IUPACtetrakis(2-[4-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexyl]propan-2-ol);2-[(1R,3R)-3-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclopentyl]propan-2-ol;2-[4-[[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]methyl]cyclohexyl]propan-2-ol;2-[4-[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]oxycyclohexyl]propan-2-ol
SMILESCc1cccc(-c2cnc3ccc(NC4CCC(C(C)(C)O)CC4)nn23)c1.Cc1cccc(-c2cnc3ccc(NC4CCC(C(C)(C)O)CC4)nn23)c1.Cc1cccc(-c2cnc3ccc(NC4CCC(C(C)(C)O)CC4)nn23)c1.Cc1cccc(-c2cnc3ccc(NC4CCC(C(C)(C)O)CC4)nn23)c1.Cc1cccc(-c2cnc3ccc(NCC4CCC(C(C)(C)O)CC4)nn23)c1.Cc1cccc(-c2cnc3ccc(N[C@@H]4CC[C@@H](C(C)(C)O)C4)nn23)c1.Cc1cccc(-c2cnc3ccc(OC4CCC(C(C)(C)O)CC4)nn23)c1
InChIInChI=1S/C23H30N4O.4C22H28N4O.C22H27N3O2.C21H26N4O/c1-16-5-4-6-18(13-16)20-15-25-22-12-11-21(26-27(20)22)24-14-17-7-9-19(10-8-17)23(2,3)28;4*1-15-5-4-6-16(13-15)19-14-23-21-12-11-20(25-26(19)21)24-18-9-7-17(8-10-18)22(2,3)27;1-15-5-4-6-16(13-15)19-14-23-20-11-12-21(24-25(19)20)27-18-9-7-17(8-10-18)22(2,3)26;1-14-5-4-6-15(11-14)18-13-22-20-10-9-19(24-25(18)20)23-17-8-7-16(12-17)21(2,3)26/h4-6,11-13,15,17,19,28H,7-10,14H2,1-3H3,(H,24,26);4*4-6,11-14,17-18,27H,7-10H2,1-3H3,(H,24,25);4-6,11-14,17-18,26H,7-10H2,1-3H3;4-6,9-11,13,16-17,26H,7-8,12H2,1-3H3,(H,23,24)/t;;;;;;16-,17-/m......1/s1
InChIKeyBVUYALXBKYAWOD-IJSRIJDMSA-N
MW2552.43 g/mol
LogP30.95
Rot. Bonds29

About tetrakis(2-[4-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexyl]propan-2-ol);2-[(1R,3R)-3-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclopentyl]propan-2-ol;2-[4-[[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]methyl]cyclohexyl]propan-2-ol;2-[4-[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]oxycyclohexyl]propan-2-ol

tetrakis(2-[4-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexyl]propan-2-ol);2-[(1R,3R)-3-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclopentyl]propan-2-ol;2-[4-[[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]methyl]cyclohexyl]propan-2-ol;2-[4-[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]oxycyclohexyl]propan-2-ol (PubChem CID 157477956) has the molecular formula C154H195N27O8 and a molecular weight of 2552.43 g/mol. Its IUPAC name is tetrakis(2-[4-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexyl]propan-2-ol);2-[(1R,3R)-3-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclopentyl]propan-2-ol;2-[4-[[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]methyl]cyclohexyl]propan-2-ol;2-[4-[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]oxycyclohexyl]propan-2-ol.

Molecular Properties

Compound Nametetrakis(2-[4-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexyl]propan-2-ol);2-[(1R,3R)-3-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclopentyl]propan-2-ol;2-[4-[[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]methyl]cyclohexyl]propan-2-ol;2-[4-[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]oxycyclohexyl]propan-2-ol
PubChem CID157477956
Molecular FormulaC154H195N27O8
Molecular Weight2552.43 g/mol
Exact Mass2550.57
IUPAC Nametetrakis(2-[4-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexyl]propan-2-ol);2-[(1R,3R)-3-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclopentyl]propan-2-ol;2-[4-[[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]methyl]cyclohexyl]propan-2-ol;2-[4-[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]oxycyclohexyl]propan-2-ol
SMILESCc1cccc(-c2cnc3ccc(NC4CCC(C(C)(C)O)CC4)nn23)c1.Cc1cccc(-c2cnc3ccc(NC4CCC(C(C)(C)O)CC4)nn23)c1.Cc1cccc(-c2cnc3ccc(NC4CCC(C(C)(C)O)CC4)nn23)c1.Cc1cccc(-c2cnc3ccc(NC4CCC(C(C)(C)O)CC4)nn23)c1.Cc1cccc(-c2cnc3ccc(NCC4CCC(C(C)(C)O)CC4)nn23)c1.Cc1cccc(-c2cnc3ccc(N[C@@H]4CC[C@@H](C(C)(C)O)C4)nn23)c1.Cc1cccc(-c2cnc3ccc(OC4CCC(C(C)(C)O)CC4)nn23)c1
InChIInChI=1S/C23H30N4O.4C22H28N4O.C22H27N3O2.C21H26N4O/c1-16-5-4-6-18(13-16)20-15-25-22-12-11-21(26-27(20)22)24-14-17-7-9-19(10-8-17)23(2,3)28;4*1-15-5-4-6-16(13-15)19-14-23-21-12-11-20(25-26(19)21)24-18-9-7-17(8-10-18)22(2,3)27;1-15-5-4-6-16(13-15)19-14-23-20-11-12-21(24-25(19)20)27-18-9-7-17(8-10-18)22(2,3)26;1-14-5-4-6-15(11-14)18-13-22-20-10-9-19(24-25(18)20)23-17-8-7-16(12-17)21(2,3)26/h4-6,11-13,15,17,19,28H,7-10,14H2,1-3H3,(H,24,26);4*4-6,11-14,17-18,27H,7-10H2,1-3H3,(H,24,25);4-6,11-14,17-18,26H,7-10H2,1-3H3;4-6,9-11,13,16-17,26H,7-8,12H2,1-3H3,(H,23,24)/t;;;;;;16-,17-/m......1/s1
InChIKeyBVUYALXBKYAWOD-IJSRIJDMSA-N
XLogP30.95
TPSA434.35 Ų
H-Bond Donors13
H-Bond Acceptors35
Rotatable Bonds29
Heavy Atoms189
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002552.43
LogP ≤ 530.95
H-Bond Donors ≤ 513
H-Bond Acceptors ≤ 1035

Analyze tetrakis(2-[4-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexyl]propan-2-ol);2-[(1R,3R)-3-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclopentyl]propan-2-ol;2-[4-[[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]methyl]cyclohexyl]propan-2-ol;2-[4-[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]oxycyclohexyl]propan-2-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of tetrakis(2-[4-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexyl]propan-2-ol);2-[(1R,3R)-3-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclopentyl]propan-2-ol;2-[4-[[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]methyl]cyclohexyl]propan-2-ol;2-[4-[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]oxycyclohexyl]propan-2-ol?
The IUPAC name of tetrakis(2-[4-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexyl]propan-2-ol);2-[(1R,3R)-3-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclopentyl]propan-2-ol;2-[4-[[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]methyl]cyclohexyl]propan-2-ol;2-[4-[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]oxycyclohexyl]propan-2-ol (CID 157477956) is tetrakis(2-[4-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexyl]propan-2-ol);2-[(1R,3R)-3-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclopentyl]propan-2-ol;2-[4-[[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]methyl]cyclohexyl]propan-2-ol;2-[4-[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]oxycyclohexyl]propan-2-ol.
What is the SMILES notation for tetrakis(2-[4-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexyl]propan-2-ol);2-[(1R,3R)-3-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclopentyl]propan-2-ol;2-[4-[[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]methyl]cyclohexyl]propan-2-ol;2-[4-[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]oxycyclohexyl]propan-2-ol?
The canonical SMILES for tetrakis(2-[4-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexyl]propan-2-ol);2-[(1R,3R)-3-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclopentyl]propan-2-ol;2-[4-[[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]methyl]cyclohexyl]propan-2-ol;2-[4-[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]oxycyclohexyl]propan-2-ol is Cc1cccc(-c2cnc3ccc(NC4CCC(C(C)(C)O)CC4)nn23)c1.Cc1cccc(-c2cnc3ccc(NC4CCC(C(C)(C)O)CC4)nn23)c1.Cc1cccc(-c2cnc3ccc(NC4CCC(C(C)(C)O)CC4)nn23)c1.Cc1cccc(-c2cnc3ccc(NC4CCC(C(C)(C)O)CC4)nn23)c1.Cc1cccc(-c2cnc3ccc(NCC4CCC(C(C)(C)O)CC4)nn23)c1.Cc1cccc(-c2cnc3ccc(N[C@@H]4CC[C@@H](C(C)(C)O)C4)nn23)c1.Cc1cccc(-c2cnc3ccc(OC4CCC(C(C)(C)O)CC4)nn23)c1.
What is the InChIKey of tetrakis(2-[4-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexyl]propan-2-ol);2-[(1R,3R)-3-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclopentyl]propan-2-ol;2-[4-[[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]methyl]cyclohexyl]propan-2-ol;2-[4-[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]oxycyclohexyl]propan-2-ol?
The InChIKey is BVUYALXBKYAWOD-IJSRIJDMSA-N. The full InChI is InChI=1S/C23H30N4O.4C22H28N4O.C22H27N3O2.C21H26N4O/c1-16-5-4-6-18(13-16)20-15-25-22-12-11-21(26-27(20)22)24-14-17-7-9-19(10-8-17)23(2,3)28;4*1-15-5-4-6-16(13-15)19-14-23-21-12-11-20(25-26(19)21)24-18-9-7-17(8-10-18)22(2,3)27;1-15-5-4-6-16(13-15)19-14-23-20-11-12-21(24-25(19)20)27-18-9-7-17(8-10-18)22(2,3)26;1-14-5-4-6-15(11-14)18-13-22-20-10-9-19(24-25(18)20)23-17-8-7-16(12-17)21(2,3)26/h4-6,11-13,15,17,19,28H,7-10,14H2,1-3H3,(H,24,26);4*4-6,11-14,17-18,27H,7-10H2,1-3H3,(H,24,25);4-6,11-14,17-18,26H,7-10H2,1-3H3;4-6,9-11,13,16-17,26H,7-8,12H2,1-3H3,(H,23,24)/t;;;;;;16-,17-/m......1/s1.
What are the key properties of tetrakis(2-[4-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexyl]propan-2-ol);2-[(1R,3R)-3-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclopentyl]propan-2-ol;2-[4-[[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]methyl]cyclohexyl]propan-2-ol;2-[4-[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]oxycyclohexyl]propan-2-ol?
tetrakis(2-[4-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexyl]propan-2-ol);2-[(1R,3R)-3-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclopentyl]propan-2-ol;2-[4-[[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]methyl]cyclohexyl]propan-2-ol;2-[4-[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]oxycyclohexyl]propan-2-ol has a molecular weight of 2552.43 g/mol, XLogP of 30.95, 29 rotatable bonds, 13 hydrogen bond donors, and 35 hydrogen bond acceptors.
Where does this data come from?
All data for tetrakis(2-[4-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexyl]propan-2-ol);2-[(1R,3R)-3-[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]cyclopentyl]propan-2-ol;2-[4-[[[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]methyl]cyclohexyl]propan-2-ol;2-[4-[3-(3-methylphenyl)imidazo[1,2-b]pyridazin-6-yl]oxycyclohexyl]propan-2-ol is sourced from PubChem (CID 157477956), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).